Biogen Inc(BIIB)
284.38
Change: -3.21 (▼ -1.13%)
As of Tue 12/20/2022 08:52 AM% Of Value
Growth
Value Per Share
:
:
:
177.40
-18.32
112.0300 (as of 19/12/2022)
Fundamentals Data
| Open | 284.90 | Dividend | 219 |
| Close Price | 284.38 | DivYield | 0 % |
| High | 285.5 | Growth | -2.4 B |
| Low | 281.59 | Growth% | -18.32 |
| P/e | 14.795 | Volume | 858,413.0 |
| P/b | 17.12 | Market Capital | 43.3 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 284.35 (as of 20/12/2022) | 50 Days Moving Average Percentage | -0.32151425345756 (as of 20/12/2022 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 12.2 B | 13.4 B | 14.3 B | 13.4 B | 10.9 B |
| Cap Spending | -1.8 B | -773.6 M | -669.5 M | -476.8 M | -276.9 M |
| Operating Expenses | 5.2 B | 5.7 B | 5.3 B | 7.0 B | 6.0 B |
| Operating Cash Flow | 5.4 B | 5.8 B | 7.0 B | 4.5 B | 2.8 B |
| Free Cash Flow | 2.7 B | 5.4 B | 6.4 B | 3.7 B | 3.3 B |
| Free Cash Flow Per Share | 12.738 | 26.423 | 34.255 | 23.325 | 22.555 |
| Total liabilities | 5.9 B | 5.9 B | 6.3 B | 7.8 B | 7.6 B |
| Total cash | 1.5 B | 1.2 B | 2.9 B | 1.3 B | 2.2 B |
| ROE% | 0.209 | 0.334 | 0.435 | 0.353 | 0.146 |
| Outstanding Shares | 211.5 M | 196.7 M | 174.0 M | 152.3 M | 146.9 M |
| P/E | 28.829 | 14.795 | 9.969 | 10.024 | 20.794 |
| P/S | 5.964 | 4.873 | 4.083 | 2.983 | 2.946 |
| Revenue USD | 12.2 B | 13.4 B | 14.3 B | 13.4 B | 10.9 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|